Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
PR ›
PROTECNOVA
Trademark search for:
PROTECNOVA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-07-07 — Application filed
2015-07-10 — Application filed
2015-07-10 — Application filed
2015-07-10 — Teas voluntary amendment received
2015-07-11 — Notice of pseudo mark e-mailed
2015-07-21 — Assigned to lie
2015-07-28 — Preliminary/voluntary amendment - entered
2015-10-16 — Assigned to examiner
2015-10-16 — Approved for pub - principal register
2015-10-19 — Law office publication review completed
2015-11-04 — Notification of notice of publication e-mailed
2015-11-24 — Published for opposition
2015-11-24 — Official gazette publication confirmation e-mailed
2016-01-19 — Noa e-mailed - sou required from applicant
2016-07-06 — Sou teas extension received
2016-07-06 — Sou extension 1 filed
2016-07-06 — Sou extension 1 granted
2016-07-08 — Notice of approval of extension request e-mailed
2016-12-22 — Sou teas extension received
2016-12-22 — Sou extension 2 filed
2016-12-22 — Sou extension 2 granted
2016-12-24 — Notice of approval of extension request e-mailed
2017-08-21 — Application abandoned
2017-08-21 — Application abandoned
2017-08-21 — Final status recorded
Owner Information
Onconova Therapeutics Inc.
Lawrenceville , NJ
Onconova Therapeutics Inc.
Lawrenceville , NJ
Correspondent
GLENN A. GUNDERSEN Dechert Llp 2929 Arch St Ste 400 Philadelphia, PA 19104-2808 UNITED STATES
Filing Details
Filing Date:
2015-07-07
Status Date:
2017-08-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.